ARCHIVES

NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy

This article is from The Cancer Letter archive.

Vol. 10 No. 41 | October 26, 1984

Download PDF Visit The Full Archive

Related Articles

In Brief: Eyre ACS President, Freeman President Elects, Kathleen Horsch Chairman, Davis Heads ASTRO

November 20, 1987

Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women

November 26, 2010

NCCS Networker Volume 9 Issue 1, Spring 1995

April 13, 1995

NCI Research Project Grant Funding To Exceed $1 Billion In Fiscal 1997

March 14, 1997

DCBDC Advisors Ok Training Grant Program In Clinical Oncology

February 22, 1991

CGOP Gets New Life, Will Move T DCT; DCPC May Fund More CCOPs with Money It Saves

July 25, 1986